STOCK TITAN

Plexus Corp Stock Price, News & Analysis

PLXS Nasdaq

Welcome to our dedicated page for Plexus news (Ticker: PLXS), a resource for investors and traders seeking the latest updates and insights on Plexus stock.

The Plexus Corp (NASDAQ: PLXS) news page on Stock Titan aggregates company announcements and third-party coverage related to its operations as an electronics manufacturing services provider. Plexus regularly issues news releases from Neenah, Wisconsin detailing its financial results, earnings guidance and participation in investor conferences.

Investors following PLXS news will find quarterly earnings announcements that include revenue, operating margin, diluted earnings per share, non-GAAP performance measures, return on invested capital, free cash flow and cash cycle metrics. The company also reports on manufacturing program wins, which represent annualized revenue when fully ramped into production, and provides commentary on working capital initiatives and share repurchase activity.

Beyond financial results, Plexus news includes notices of upcoming earnings release dates and conference calls, as well as participation in events such as institutional investor conferences. These items provide context on how and when management communicates with the investment community.

News items may also reference customer partnerships that rely on Plexus’ design, supply chain, manufacturing and sustaining services capabilities, illustrating how the company supports complex products in aerospace/defense, healthcare/life sciences and industrial markets. For anyone tracking PLXS stock, this page offers a centralized view of the company’s official updates and related coverage over time.

Rhea-AI Summary

Plexus reported record fiscal fourth quarter revenue of $913 million, exceeding guidance expectations and contributing to a total fiscal year revenue of $3.4 billion, a 7% increase from the previous year. The fourth quarter GAAP diluted EPS was $1.26, including $0.23 stock-based compensation. For the fiscal first quarter of 2021, the company projects revenue between $810 million and $850 million with GAAP diluted EPS guidance of $1.02 to $1.17. Free cash flow reached $160 million for the year, indicating solid financial stability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.07%
Tags
-
Rhea-AI Summary

Plexus (NASDAQ: PLXS) will release its fiscal Q4 2020 results on October 28, 2020, after market close. A conference call will follow on October 29, 2020, at 8:30 a.m. ET. Investors can access the call via webcast on the company's website, plexus.com. The call will include discussions on the financial performance and operational insights for Q4. Key metrics and guidance are expected to be shared during the call, which will also be available for replay.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.08%
Tags
-
Rhea-AI Summary

Plexus (PLXS) will release its fiscal Q4 2020 results after market close on October 28, 2020. A conference call to discuss these results will take place on October 29, 2020, at 8:30 a.m. ET. Interested participants can access the live webcast via the investor relations section of Plexus' website. The call will also be available via telephone, with a replay option thereafter. Plexus, a leading global provider of product realization services, is focused on developing complex products in regulated industries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.08%
Tags
Rhea-AI Summary

Plexus announced a strategic partnership with Quidel Corporation to enhance the production of the Sofia®2 Fluorescent Immunoassay Analyzer. This collaboration aims to meet the rising demand for point-of-care testing, particularly in the COVID-19 response. The Sofia®2 system is notable for delivering accurate results in under 15 minutes for various infectious diseases. Plexus will leverage its expertise in healthcare manufacturing to support this initiative, thereby contributing to improved diagnostic capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.35%
Tags
none
-
Rhea-AI Summary

Plexus announced a partnership with Quidel Corporation on September 28, 2020, to support the manufacturing and supply chain solutions for the Sofia®2 Fluorescent Immunoassay Analyzer. This collaboration aims to meet the rising demand for point-of-care testing in the fight against COVID-19. The Sofia®2 system delivers quick, accurate diagnostic results for critical conditions, including COVID-19 and influenza. Plexus will utilize its expertise in healthcare and life sciences to enhance production capabilities, contributing significantly to healthcare providers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.35%
Tags
none
-
Rhea-AI Summary

Plexus (NASDAQ: PLXS) has authorized a new share repurchase program for up to $50 million of its common stock, starting after the expiration of the previous program. This initiative aims to enhance shareholder value and is expected to run through fiscal 2021. The buyback amount represents about 2% of the company's current market capitalization. While there is no specific schedule for these repurchases, Plexus intends to execute them consistently based on market conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
buybacks
Rhea-AI Summary

Plexus reported a record revenue of $857 million for the fiscal third quarter ending July 4, 2020, with a GAAP diluted EPS of $1.20. For the fiscal fourth quarter, the company provides guidance of $850 to $890 million in revenue and $1.05 to $1.20 in GAAP diluted EPS. The company secured 35 new manufacturing programs, projecting an annualized revenue of $252 million. The operating margin reached 5.3%, the highest in three years, while return on invested capital (ROIC) stood at 12.9%, resulting in an economic return of 4.1%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.5%
Tags
-
Rhea-AI Summary

Plexus (NASDAQ: PLXS) will release its fiscal Q3 2020 results on July 22, 2020, after market close. A conference call to discuss the results is scheduled for July 23, 2020, at 8:30 a.m. Eastern Time. Investors can access the call via the company's website or by dialing +1.866.922.5180 with the passcode: 9483228. The call will also be archived for later access. Plexus has been operating since 1979, specializing in product realization and providing comprehensive solutions across industries with complex products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
-
Rhea-AI Summary

Plexus (NASDAQ: PLXS) will participate in the 15th Annual Needham Virtual Technology & Media Conference on May 20, 2020. The event features a fireside chat with Plexus' management team at 10:00 a.m. Eastern Time, accessible via live webcast. Following the live session, a replay will be available for 30 days. Plexus has been a partner in product realization since 1979, focusing on design, supply chain solutions, manufacturing, and aftermarket services across various complex industries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.91%
Tags
none

FAQ

What is the current stock price of Plexus (PLXS)?

The current stock price of Plexus (PLXS) is $190.74 as of March 13, 2026.

What is the market cap of Plexus (PLXS)?

The market cap of Plexus (PLXS) is approximately 5.1B.

PLXS Rankings

PLXS Stock Data

5.08B
26.27M
Electronic Components
Printed Circuit Boards
Link
United States
NEENAH

PLXS RSS Feed